Rothschild & Co Asset Management US’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-393,839
| Closed | -$14.6M | – | 295 |
|
|
2020
Q3 | $14.6M | Sell |
393,839
-33,429
| -8% | -$1.24M | 0.26% | 157 |
|
|
2020
Q2 | $21.9M | Buy |
427,268
+39,685
| +10% | +$2.04M | 0.32% | 123 |
|
|
2020
Q1 | $12.2M | Buy |
387,583
+92,502
| +31% | +$2.92M | 0.19% | 190 |
|
|
2019
Q4 | $17.6M | Buy |
295,081
+278,834
| +1,716% | +$16.6M | 0.18% | 204 |
|
|
2019
Q3 | $596K | Sell |
16,247
-149
| -0.9% | -$5.47K | 0.01% | 331 |
|
|
2019
Q2 | $763K | Sell |
16,396
-217
| -1% | -$10.1K | 0.01% | 327 |
|
|
2019
Q1 | $667K | Sell |
16,613
-10,513
| -39% | -$422K | 0.01% | 344 |
|
|
2018
Q4 | $1.25M | Sell |
27,126
-255
| -0.9% | -$11.7K | 0.02% | 341 |
|
|
2018
Q3 | $1.22M | Buy |
27,381
+3,644
| +15% | +$162K | 0.01% | 353 |
|
|
2018
Q2 | $930K | Buy |
23,737
+4,818
| +25% | +$189K | 0.01% | 358 |
|
|
2018
Q1 | $1.37M | Sell |
18,919
-1,952
| -9% | -$141K | 0.02% | 335 |
|
|
2017
Q4 | $1.37M | Sell |
20,871
-1,554
| -7% | -$102K | 0.01% | 329 |
|
|
2017
Q3 | $1.12M | Buy |
+22,425
| New | +$1.12M | 0.01% | 324 |
|